Formulation Strategies to Optimize the In Vitro Release of Fenbendazole from Immediate-Release Tablets Containing Amorphous Hydroxypropyl-β-Cyclodextrin Inclusion Complexes

Background/Objectives: The aim of this study is to obtain new inclusion complexes of fenbendazole (FEN) with hydroxypropyl-β-cyclodextrin (HP-β-CD) in order to optimize the in vitro release profile of fenbendazole from immediate-release tablets. Methods: Inclusion complexes and solid dispersions were prepared by coprecipitation, lyophilization, and kneading at 1:0.25 and 1:0.5 (FEN:HP-β-CD) sub-stoichiometric molar ratios. Physical mixtures were prepared for comparison. Both physical mixtures and inclusion complexes were subsequently evaluated using physicochemical and pharmacotehnical methods. Results: Physicochemical analysis (FTIR, XRD, and TG/DTA) showed that lyophilization successfully induced solid-state amorphization of the drug at both ratios. Directly compressed tablets exhibited excellent mechanical properties, with crushing strength ranging from 65.1 ± 2.4 N (F3) to 87.4 ± 2.9 N (F2) and 98.2 ± 3.5 N (F1), friability below 0.7%, and rapid disintegration (58 ± 3.2 s for F1, 69 ± 4.1 s for F2, and 77 ± 4.5 s for F3). In vitro dissolution was strongly medium-dependent: at pH 1.2, cyclodextrin-based tablets achieved near-complete dissolution within 60 min (Q60 = 96.8 ± 2.1, DE% = 81.8 ± 1.9% for F1; Q60 = 99.5 ± 1.8%, DE% = 71.4 ± 2.3% for F2), compared with the uncomplexed drug (Q60 = 63.3 ± 2.4%, DE% = 47.5 ± 1.7% for F3). At pH 4.5 and 6.8, drug release plateaued below 15% and 38%, respectively, due to non-sink saturation constraints. Conclusions: This study provides in vitro proof of concept that sub-stoichiometric amorphization with HP-β-CD, coupled with direct compression, overcomes the gastric dissolution barrier of fenbendazole, establishing a solid biopharmaceutical basis for future in vivo bioavailability and stability evaluations.

Authors

Institutions

Publication Details

Journal
Pharmaceutics
Published
2026-11-18
DOI
https://doi.org/10.3390/pharmaceutics18111490
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Formulation Strategies to Optimize the In Vitro Release of Fenbendazole from Immediate-Release Tablets Containing Amorphous Hydroxypropyl-β-Cyclodextrin Inclusion Complexes

Ancuța Cătălina Fița, Daniela Cristina Culita, Veronica Brătan, Ramona Pârvănescu et al.
Pharmaceutics
Drug Solubulity and Delivery Systems
article

Formulation Strategies to Optimize the In Vitro Release of Fenbendazole from Immediate-Release Tablets Containing Amorphous Hydroxypropyl-β-Cyclodextrin Inclusion Complexes

Ancuța Cătălina Fița, Daniela Cristina Culita, Veronica Brătan, Ramona Pârvănescu, Vasile-Adrian Surdu, Emma Adriana Ozon, Adina Magdalena Musuc, Ion Mircioiu, Codruţa Şoica, Cristina Maria Trandafirescu
article en

Abstract

Background/Objectives: The aim of this study is to obtain new inclusion complexes of fenbendazole (FEN) with hydroxypropyl-β-cyclodextrin (HP-β-CD) in order to optimize the in vitro release profile of fenbendazole from immediate-release tablets. Methods: Inclusion complexes and solid dispersions were prepared by coprecipitation, lyophilization, and kneading at 1:0.25 and 1:0.5 (FEN:HP-β-CD) sub-stoichiometric molar ratios. Physical mixtures were prepared for comparison. Both physical mixtures and inclusion complexes were subsequently evaluated using physicochemical and pharmacotehnical methods. Results: Physicochemical analysis (FTIR, XRD, and TG/DTA) showed that lyophilization successfully induced solid-state amorphization of the drug at both ratios. Directly compressed tablets exhibited excellent mechanical properties, with crushing strength ranging from 65.1 ± 2.4 N (F3) to 87.4 ± 2.9 N (F2) and 98.2 ± 3.5 N (F1), friability below 0.7%, and rapid disintegration (58 ± 3.2 s for F1, 69 ± 4.1 s for F2, and 77 ± 4.5 s for F3). In vitro dissolution was strongly medium-dependent: at pH 1.2, cyclodextrin-based tablets achieved near-complete dissolution within 60 min (Q60 = 96.8 ± 2.1, DE% = 81.8 ± 1.9% for F1; Q60 = 99.5 ± 1.8%, DE% = 71.4 ± 2.3% for F2), compared with the uncomplexed drug (Q60 = 63.3 ± 2.4%, DE% = 47.5 ± 1.7% for F3). At pH 4.5 and 6.8, drug release plateaued below 15% and 38%, respectively, due to non-sink saturation constraints. Conclusions: This study provides in vitro proof of concept that sub-stoichiometric amorphization with HP-β-CD, coupled with direct compression, overcomes the gastric dissolution barrier of fenbendazole, establishing a solid biopharmaceutical basis for future in vivo bioavailability and stability evaluations.

PharmaceuticsVol. 18(11)
Titu Maiorescu University (RO), Carol Davila University of Medicine and Pharmacy (RO), Transylvania University of Brașov (RO), Victor Babeș University of Medicine and Pharmacy Timișoara (RO), Romanian Academy (RO)
Good health and well-being
Drug Solubulity and Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon